Concepedia

Andi Leubitz

AL

Statistics

Publications

2

Citations

103

H-Index

2

Active since

2019

Affiliations

SGS (Belgium)(Current)

Eloxx Pharmaceuticals (United States)

Andi Leubitz is an author at SGS (Belgium).

Publications per year

2019–2021

2

Publications

2

Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX‐02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers

Andi Leubitz, Anat Frydman‐Marom, Neal Sharpe et al. · Clinical Pharmacology in Drug Development · 2019 · 69 citations · Full text

A Randomized, Double‐Blind, Placebo‐Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX‐02 in Healthy Subjects

Andi Leubitz, Frédéric Vanhoutte, Ming‐yi Hu et al. · Clinical Pharmacology in Drug Development · 2021 · 34 citations · Full text

1–2 of 2